Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
Saptarshi Sinha, Vanessa Castillo, Celia R. Espinoza, et al.
EBioMedicine (2022) Vol. 82, pp. 104185-104185
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
Paula David, Saptarshi Sinha, Khizer Iqbal, et al.
EBioMedicine (2024) Vol. 104, pp. 105136-105136
Open Access | Times Cited: 14
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
Puja Mehta, Iván O. Rosas, Mervyn Singer
Intensive Care Medicine (2022) Vol. 48, Iss. 12, pp. 1803-1806
Open Access | Times Cited: 38
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
Filippo Patrucco, Paolo Solidoro, Francesco Gavelli, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 895-895
Open Access | Times Cited: 30
Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis
Tanyalak Parimon, Peter Chen, Barry R. Stripp, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 2, pp. C483-C495
Closed Access | Times Cited: 23
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 77-83
Open Access | Times Cited: 22
Organoids and organoids-on-a-chip as the new testing strategies for environmental toxicology-applications & advantages
Chengyu Hu, Sheng Yang, Tianyi Zhang, et al.
Environment International (2024) Vol. 184, pp. 108415-108415
Open Access | Times Cited: 11
Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study
Bo‐Guen Kim, Hyun Lee, Cho Yun Jeong, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 10
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
Laura Bergantini, Alessandro Mainardi, Miriana d’Alessandro, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
Ruyan Wan, Lan Wang, Miaomiao Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16410-16410
Open Access | Times Cited: 17
Epithelial stem cells and niches in lung alveolar regeneration and diseases
Jilei Zhang, Yuru Liu
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 1, pp. 17-26
Open Access | Times Cited: 6
Neutrophil Activity and Extracellular Matrix Degradation: Drivers of Lung Tissue Destruction in Fatal COVID-19 Cases and Implications for Long COVID
Teluguakula Narasaraju, Indira Neeli, Sheila Criswell, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 236-236
Open Access | Times Cited: 4
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung
Joel S. Greenberger, Wen‐Chi Hou, Donna Shields, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1546-1556
Open Access | Times Cited: 4
Pharmacological approaches to pulmonary fibrosis following COVID-19
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Impaired autophagy-accelerated senescence of alveolar type II epithelial cells drives pulmonary fibrosis induced by single-walled carbon nanotubes
Xiang Zhang, Xinxin Hu, Yuqing Zhang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Cell Crosstalk in Alveolar Microenvironment: From Lung Injury to Fibrosis
Li‐Cheng Song, Kuan Li, Huaiyong Chen, et al.
American Journal of Respiratory Cell and Molecular Biology (2024) Vol. 71, Iss. 1, pp. 30-42
Closed Access | Times Cited: 3
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report
Sara C. Auld, Ajay Sheshadri, Jennifer Alexander‐Brett, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 9, pp. 1219-1237
Closed Access | Times Cited: 3
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection
Panagiotis Κeramidas, Maria Pitou, Eleni Papachristou, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4286-4308
Open Access | Times Cited: 2
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
Tingwei Zhang, Jinjin Zhang, Changjun Lv, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence
Yijie Li, Ranyun Chen, Jianzhi Wu, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 620-635
Open Access | Times Cited: 6
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability
Gibran Ali, Mo Zhang, Jianjun Chang, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Hydrogen sulfide inhibits alveolar type II cell senescence and limits pulmonary fibrosis via promoting MDM2‐mediated p53 degradation
Xiuli Wang, Yi‐Tong Xu, Shu‐Li Zhang, et al.
Acta Physiologica (2023) Vol. 240, Iss. 1
Closed Access | Times Cited: 5
Interleukin-11 causes alveolar type 2 cell dysfunction and prevents alveolar regeneration
Benjamin Ng, Kevin Huang, Chee Jian Pua, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing
Letizia Bernardo, Andrea Lomagno, Pierluigi Mauri, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1196-1196
Open Access | Times Cited: 4
Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
Rajesh Swarnakar, Yogesh Garje, Neeraj Markandeywar, et al.
Lung India (2022) Vol. 39, Iss. 3, pp. 279-285
Open Access | Times Cited: 5
Interleukin-11 causes alveolar type 2 cell dysfunction and prevents alveolar regeneration
Benjamin Ng, Kevin Huang, Chee Jian Pua, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top